Remimazolam As a Sole Sedative Agent for Gastrostomy Tubes Placed in the Interventional Radiology Suite: A Case Series.

Autor:	Shapiro AB; From the Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida.; Department of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida., Smith MA; From the Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida.; Department of Critical Care Medicine, Mayo Clinic, Jacksonville, Florida., Moshe CT; From the Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida., Frey GT; Department of Radiology, Mayo Clinic, Jacksonville, Florida., Chadha RM; From the Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, Florida.
Jazyk:	angličtina
Zdroj:	A&A practice [A A Pract] 2024 Aug 06; Vol. 18 (8), pp. e01839. Date of Electronic Publication: 2024 Aug 06 (Print Publication: 2024).
DOI:	10.1213/XAA.0000000000001839
Abstrakt:	Remimazolam is an ultrashort acting intravenous sedative-hypnotic approved for procedural sedation. We report a series of 8 cases of radiographically placed gastrostomy tubes using remimazolam as the sole anesthetic agent. Interventional radiology (IR) gastrostomy tube placement entails anesthetizing often complex patients in a nonoperating room environment. All 8 patients reported here underwent successful gastrostomy tube placement without the need for conversion to general anesthesia. Remimazolam is a feasible option to sedate patients for gastrostomy tube placement in the IR suite. Competing Interests: The authors declare no conflicts of interest. (Copyright © 2024 International Anesthesia Research Society.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu